Digital tool to identify and monitor regorafenib-associated hand-foot skin reactions: A proof-of-concept study protocol.
Fiche publication
Date publication
mai 2023
Journal
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MANFREDI Sylvain
Tous les auteurs :
Coriat R, Sibaud V, Bourgeois V, Manfredi S, Artru P, Trouilloud I, Kremliovski M, Arvis P, Palma MD
Lien Pubmed
Résumé
The FACET study is a prospective, open-label, low risk interventional clinical trial aiming at exploring the fitness-for-purpose and usability of an electronic device suite for the detection of hand-foot skin reaction symptoms in patients with metastatic colorectal cancer treated with regorafenib.
Mots clés
Digital device, Metastatic colorectal cancer, Patient-reported outcomes, Regorafenib treatment
Référence
Dig Liver Dis. 2023 05 20;: